Recurrent Non-Small Cell Lung Carcinoma
Oncology
3
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Small Molecule
1100%
+ 2 programs with unclassified modality
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Bristol Myers SquibbLaboratory Biomarker Analysis
NovartisBinimetinib
Clinical Trials (2)
Total enrollment: 17 patients across 2 trials
Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery
Start: Jul 2017Est. completion: Sep 202117 patients
Phase 2Unknown
Binimetinib With Docetaxel in Treating Patients With Previously Treated, Stage IV Non-small Cell Lung Cancer
Start: Jun 2016Est. completion: Jun 20190
Phase 1Withdrawn
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
9m ago
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
9m ago
Office Administrator
SystImmune
9m ago
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
20m ago
Working Student Office Management Support (m/f/d)
Mindpeak
Hamburg
23m ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
23m ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space